• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

EyeGage is building a database of eye scans for drug testing

September 21, 2021 by David Barret Leave a Comment

LaVonda Brown developed an interest in eye-tracking during her time at Georgia Tech. The fascination with all the information that can be derived by scanning the so-called Windows to the Soul formed the foundation of EyeGage, one of the 20 companies competing at this year’s Disrupt Startup Battlefield.

The startup’s entry into the TechCrunch competition arrives as EyeGage launches its first product: an app designed to let users know if they’re sober enough to drive. If not, they’ll get a big red “Do Not Drive” warning and a link to call either an Uber or Lyft. The application is free and serves a dual purpose. In addition to the obvious consumer-facing purposes, it doubles as an opt-in for EyeGage’s growing dataset of eyes.

“Consumers can download the app, take pictures of their eyes and then we can suggest whether or not they should use rideshare. Essentially not driving, based on their eyes,” explains Brown. “That is free. I like to call it a barter subscription service. They give us pictures and videos of their eyes and we give them access to the technology so they can make a responsible decision.”

The app is the most forward-facing aspect of EyeGage’s business at the moment – and like most of what the company does, it will go toward building out its dataset of eyes. The company will start with measuring the impact of alcohol on various aspects of the eyes, including studies it’s currently conducting with participants in a federally approved testing facility. Those who sign forms to participate will drink booze, while the company collects images and videos of their eyes, along with a blood sample.

Marijuana is next on the list, given its current legal status in certain states. Other drugs like opioids, amphetamines and benzodiazepines will be more difficult to gather, though hospitals and clinics that mete out legal versions of these substances could prove a good source for collecting that data – with the proper consent.

Brown says workplace environments are a logical next step, as well. Law enforcement is also on the list, though there are various hurdles to attaining those sorts of partnerships. “We’re targeting high-risk workplaces like construction, manufacturing and transportation. In those industries in particular they have a high rate of drug and alcohol use,” she tells TechCrunch.

There may also be a potential use for the company’s dataset beyond its immediate use for detecting substances in the body.

“Monitoring eye behavior can be used for so many domains,” Brown adds. “And, of course, you can identify someone by their eyes. It can be used to diagnose certain illnesses, concussions or diabetes, and it can be used in different market segments. Your eyes are so informative about what’s going on in your body. They can tell if you’ve had caffeine, depending on how it responds to light. If it’s too fast, it’s some kind of stimulant. If it’s too slow, it’s some kind of depressant.”

EyeGage has raised $142,455, to date. That includes $42,455 in pre-seed from friends and family, as well as a recent award of $100,000 from Google Black Founders Fund.

Source Link EyeGage is building a database of eye scans for drug testing

David Barret
David Barret

Related posts:

  1. Tennis-Sabalenka defeats Mertens in straight sets in U.S. Open fourth round
  2. China’s export, import growth likely eased in Aug on COVID-19 cases, supply bottlenecks: Reuters poll
  3. Apple and Google bow to pressure in Russia to remove Kremlin critic’s tactical voting app
  4. Iran joins expanding Asian security body led by Moscow, Beijing

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • Gluten-Free By Necessity: Busting 5 Myths And Misconceptions About Celiac Disease
  • Watch Live Today As Private Resilience Spacecraft Lands In “Cold Sea” Region Of The Moon
  • Myth Vs. Medicine: The Truth About Nature’s Healing Power
  • Dead Sea Scrolls May Have Been Written By Original Authors Of The Bible
  • The World’s Oldest-Ever Cat Lived On A Delicious-Sounding Diet – Including Wine
  • Next Megatsunami May Sink Parts Of The Pacific Northwest Coast By Up To 2 Meters
  • Magnetic Curtains As Wide As A City Seen On The Sun In Unexpected Findings
  • The Colorado River Basin Has Lost Enough Groundwater Alone To Fill Lake Mead
  • Ping-Pong Sponges, Dragonfish, And Snailfish Eggs Delight Scientists Exploring The Planet’s Most Remote Trenches
  • Morenci Mine, The Largest Copper Mine In US, Is A Sight To Behold
  • The Standard Model Saved Once More Thanks To The Most Precise Muon Measurement
  • New Study Rules Out Popular Version Of The Simulation Hypothesis
  • What Is Trump’s “Gold Standard Science” Actually About?
  • Suspect Accused Of Fowl Play In Scrubbed Australian Rocket Launch Is Innocent
  • Two Yangtze Finless Porpoises Have Been Returned To The Wild For First Time In China
  • Sun Filtered By Dust In Florida As Haboob The Size Of 48 States Approaches The US
  • What Is The Alaska Triangle?
  • “Egyptian Blue” Was A Color Lost To History. Finally, We Can Make It Again
  • Satellite Image Shows A Human Head Peering Out Of The Landscape In Canada
  • Video Shows Physicists Achieve “Impossible” Feat Of Rolling A Ball Vertically
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version